China SXT Pharmaceuticals (SXTC) Current Deferred Revenue (2018 - 2026)
China SXT Pharmaceuticals (SXTC) posted quarterly Current Deferred Revenue of $104423.0 for Q1 2026, up 78.11% year-over-year from $58627.0 in Q1 2025, and up 60.51% quarter-over-quarter from $65057.0 in Q3 2025.
China SXT Pharmaceuticals (SXTC) Current Deferred Revenue (2018 - 2026) Analysis & Trends
China SXT Pharmaceuticals' Current Deferred Revenue history runs 9 years deep, the most recent figure standing at $104423.0 for Q1 2026.
- In Q1 2026, Current Deferred Revenue rose 78.11% year-over-year to $104423.0; the TTM figure through Mar 2026 stood at $104423.0 (up 78.11% YoY), while the FY2026 annual figure was $104423.0, up 78.11% from the prior year.
- Current Deferred Revenue for Q1 2026 stood at $104423.0, up from $65057.0 in the prior quarter.
- The five-year high for Current Deferred Revenue was $190340.0 in Q3 2024, with the low at $58627.0 in Q1 2025.
- The 5-year median for Current Deferred Revenue is $104423.0 (2026), against an average of $122700.7.
- The sharpest annual moves came in 2022 and 2023: Current Deferred Revenue plunged 70.23% in 2022, then jumped 192.15% in 2023.
- China SXT Pharmaceuticals' Current Deferred Revenue stood at $65101.0 in 2022, then surged by 192.15% to $190193.0 in 2023, then rose by 0.08% to $190340.0 in 2024, then sank by 65.82% to $65057.0 in 2025, then surged by 60.51% to $104423.0 in 2026.
- Business Quant data shows SXTC's Current Deferred Revenue at $104423.0 in Q1 2026, $65057.0 in Q3 2025, and $58627.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | China SXT Pharmaceuticals | 32,992.52 | -28.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 104,423.00 |
| Sep 30, 2025 | 65,057.00 |
| Mar 31, 2025 | 58,627.00 |
| Sep 30, 2024 | 190,340.00 |
| Mar 31, 2024 | 187,665.00 |
| Sep 30, 2023 | 190,193.00 |
| Mar 31, 2023 | 165,534.00 |
| Sep 30, 2022 | 65,101.00 |
| Mar 31, 2022 | 77,366.00 |
| Sep 30, 2021 | 218,644.00 |
| Mar 31, 2021 | 257,449.00 |
| Sep 30, 2020 | 217,412.00 |
| Mar 31, 2020 | 298,042.00 |
| Sep 30, 2019 | 120,575.00 |
| Mar 31, 2019 | 57,553.00 |
| Sep 30, 2018 | 117,992.00 |
| Mar 31, 2018 | 292,947.00 |